Search

Search Results
Results 8011 - 8020 of 8228 for Skin Cancer
  • Mersynofen
    Drug - 23 Oct 2024
    Consumer Medicine Information (CMI) about Mersynofen intended for persons living in Australia.
  • Resprim
    Drug - 21 Oct 2024
    Consumer Medicine Information (CMI) about Resprim intended for persons living in Australia.
  • Nordip
    Drug - 15 Oct 2024
    Consumer Medicine Information (CMI) about Nordip intended for persons living in Australia.
  • Ramipril Viatris
    Drug - 14 Oct 2024
    Consumer Medicine Information (CMI) about Ramipril Viatris (ramipril) intended for persons living in Australia.
  • C-Flox
    Drug - 14 Oct 2024
    Consumer Medicine Information (CMI) about C-Flox (ciprofloxacin) intended for persons living in Australia.
  • Alphaclav Duo Viatris 500/125 and Alphaclav Duo Forte Viatris 875/125
    Drug - 8 Oct 2024
    Consumer Medicine Information (CMI) about Alphaclav Duo Viatris 500/125 and Alphaclav Duo Forte Viatris 875/125 intended for persons living in Australia.
  • Terimide
    Drug - 3 Oct 2024
    Consumer Medicine Information (CMI) about Terimide intended for persons living in Australia.
  • DBL Sulfamethoxazole and Trimethoprim
    Drug - 1 Oct 2024
    Consumer Medicine Information (CMI) about DBL Sulfamethoxazole and Trimethoprim intended for persons living in Australia.
  • Targocid
    Drug - 30 Sep 2024
    Consumer Medicine Information (CMI) about Targocid intended for persons living in Australia.
  • Cosdor
    Drug - 30 Sep 2024
    Consumer Medicine Information (CMI) about Cosdor (Dorzolamide hydrochloride/Timolol maleate) intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback